The emergence of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable buzz within the healthcare community. This novel dual GIP and GLP-1 target medication seems to offer notable improvements in fat shedding compared to existing therapies. Initial research studies have demonstrated si